Dana Pizzuti, the Chief Med and Dev Officer of $CRNX, sold 127 shares of the company on 03-19-2025 for an estimated $4,423. We received data on the trade from a ...
In other news, insider Dana Pizzuti sold 2,515 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $34.20, for a total ...
Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) by 24.5% during the fourth quarter, HoldingsChannel.com reports.
After hours: March 21 at 5:29:10 PM EDT Loading Chart for DAN ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results